Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Lymphoma, Mantle-Cell 6 Lymphoma, Large B-Cell, Diffuse 6 Lymphoma 6 Burkitt Lymphoma 6 Small Cell Lung Carcinoma 5 Lymphoma, T-Cell 4 Lymphoma, Follicular 4 Waldenstrom Macroglobulinemia 3 Ovarian Neoplasms 3 Neuroblastoma 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Leukemia, Myeloid, Acute 3 Immunoblastic Lymphadenopathy 3 Head and Neck Neoplasms 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hodgkin Disease 2 Gastrointestinal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2

Interventions

Cyclophosphamide 16 Etoposide 14 Carboplatin 11 Temozolomide 10 Vincristine 9 Granulocyte Colony-Stimulating Factor 9 Filgrastim 9 Magnetic Resonance Spectroscopy 8 Cisplatin 8 etoposide phosphate 7 X-Rays 7 Thiotepa 7 Phantoms, Imaging 7 Methotrexate 7 Topotecan 6 Specimen Handling 6 Radiotherapy 6 tazemetostat 5 Stem Cell Transplantation 5 Nuclear Medicine Department, Hospital 5 fludarabine 4 Peripheral Blood Stem Cell Transplantation 4 Mesna 4 Melphalan 4 Biopsy 4 palbociclib 3 Sirolimus 3 Nivolumab 3 Leucovorin 3 Irinotecan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Rhabdoid Tumor × MLN 8237 × Clear all

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡